Search results

Two researchers from the Department of Pharmacy initiated the project: Romain Siriez and Constant Gillot. Under the supervision of Professor Jean-Michel Dogné, they imagined creating a real pharmacy, which would be the ideal place to practice innovative pedagogy, essential for the training of master's students during specialized pharmacotherapy.

As the largest and heaviest organ in the human body, the skin is the focus of Professor Yves Poumay's research. For nearly 30 years, within the Cells and Tissues laboratory (LabCeTi), he has been developing in vitro epidermal models that reproduce skin pathologies to better understand and treat them. A pioneering approach that offers alternatives to animal experimentation! On the eve of an international congress devoted to dermatology research organised at UNamur (see below), he talks about the importance of melanoma screening and details the latest advances in dermatology made in his laboratory.

From 13 to 17 March 2023, the Cercle Médecine is organising a week to raise awareness of addiction and alcohol consumption. Various activities are proposed. The organisers want to make some students aware of their consumption.

On Thursday March 16, 2023, the Government of the Wallonia-Brussels Federation debated the file of authorization requests for higher education. The UNamur reveals elements supporting the merits of its request to organize specialization in medicine general. Six questions to better understand.

The Elongator complex is involved in the addition of 5'-carboxylmethyluridine (cm5U)-derived modifications to transfer RNAs (tRNAs), thereby influencing the translation of certain messenger RNAs (mRNAs) and helping to maintain the integrity of the proteome. This complex is involved in a variety of biological processes, and is of particular importance in oncology. The identification of chemical inhibitors of Elongator is of significant interest in both basic and pharmaceutical research.Through a yeast screen, this work reveals a potential new role for Elongator and identifies a chemical inhibitor of the complex. This compound presents itself as an interesting candidate as a pharmacological inhibitor, opening up new perspectives for the search for anti-cancer therapies.

COVID-19 is an infectious disease caused by SARS-CoV-2. COVID-19 was quickly declared a pandemic by the World Health Organization (WHO) on March 11, 2020.At the start of the pandemic, healthcare professionals were faced with the marketing of numerous kits designed to measure binding antibodies. The role of neutralizing antibodies as the best correlate of protection against SARS-CoV-2 infection was quickly highlighted. A neutralization assay with the use of pseudovirus was therefore developed by our team and compared with several binding assays.There have been considerable efforts to produce and clinically validate new vaccines against COVID-19. The CRO-VAX HCP study was designed to assess the humoral response in a population of healthcare professionals who had received two doses of COVID-19 BNT162b2 vaccine.Given the decline in vaccine efficacy over time and the emergence of variants likely to evade immunity, a third dose was quickly recommended by the authorities to boost immunity. This was administered to 155 volunteers in the CRO-VAX HCP study.Still facing a decline in vaccine efficacy over time and the emergence of new variants, a second adapted booster was proposed. In September 2022, 54 participants in the CRO-VAX HCP study received this second booster. The humoral response was assessed and neutralizing antibodies against several variants were measured. In addition, we also measured the cellular response using an interferon-gamma release assay. Compared with the humoral response, which declines considerably over time, the cellular response remained fairly stable. This could therefore explain why individuals with low antibody titers can still be protected against a severe form of the disease .

The aim of the PharmaNam alumni association is to maintain and strengthen the ties that bind together former students who have completed at least one full cycle of studies in Pharmaceutical Sciences at the University of Namur. In addition, the association supports the Pharmacy Department, guides students in their choice of a career in pharmacy, and strengthens professional and academic relations through events such as banquets and conferences.

On October 25, 2024, the University of Namur is organizing the 2nd edition of its Job Fair in the field of health sciences. The event will bring together companies in the BioPharma sector in Belgium and Wallonia with our bachelor, master and PhD students in biomedical sciences and pharmacy.

On March 4 and 5, UNamur hosted the launch event for the European ERAMET project. Led by Professor Flora Musuamba Tshinanu, this collaborative project brings together 17 European partners. Objective: to improve the scientific database guiding regulators in drug evaluation, with a focus on rare and pediatric conditions. A look back at the launch day.

Research in the Department of Psychology includes the study of cognition and emotion interactions through different techniques (behavioral, pharmacological, electrophysiological and neuroimaging), different states (wakefulness, sleep, hypnosis and meditation) and in different populations (healthy people, people with mood disorders, people with anxiety disorders, people with substance abuse, ...). They also concern the field of eHealth and include collaborations on research projects using mobile applications to track health and well-being.

Created in 1978, the Department of Psychology has carried out extensive research in various fields of the humanities and social sciences as well as health, with a particular interest in vulnerable people, neuroscience and eHealth.